1149336 Ontario, Inc.

Patent Owner

Watch Compare Add to Portfolio

Stats

Details

Patent Activity in the Last 10 Years

Technologies

Intl Class Technology Matters Rank in Class
 
 
 
A61K PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES 22233
 
 
 
C07K PEPTIDES 4132
 
 
 
G01N INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES 3203
 
 
 
A01N PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF 194
 
 
 
A61P THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS 148

Top Patents (by citation)

Upgrade to the Professional Level to View Top Patents for this Owner. Learn More

Recent Publications

  • No Recent Publications to Display

Recent Patents

Patent # Title Filing Date Issue Date Intl Class
9044424 Methods of regulating glucose metabolism, and reagents related theretoJul 25, 13Jun 02, 15[A61K]
8933039 Glucagon-like peptide-2 analogsJun 15, 10Jan 13, 15[A61K, G01N, C07K]
8846625 Glucagon-like peptide-2 analogsMar 11, 13Sep 30, 14[A61K, G01N, C07K]
8513190 Method of regulating glucose metabolism, and reagents related theretoNov 16, 11Aug 20, 13[A61K]
8318669 Method of regulating glucose metabolism, and reagents related theretoNov 09, 10Nov 27, 12[A61K]
7960344 Methods of enhancing functioning of the large intestineOct 16, 09Jun 14, 11[A61K, G01N]
7829530 Method of regulating glucose metabolism, and reagents related theretoNov 26, 08Nov 09, 10[A61K]
7459428 Method of regulating glucose metabolism, and reagents related theretoJul 17, 06Dec 02, 08[A61K]
7176182 Methods of enhancing functioning of the large intestineApr 21, 03Feb 13, 07[A61K]
7157429 Method of regulating glucose metabolism, and reagents related theretoJul 28, 00Jan 02, 07[A61K]

View all patents..

Expired/Abandoned/Withdrawn Patents

Patent # Title Status Filing Date Issue/Pub Date Intl Class
2016/0000,857 Method of Regulating Glucose Metabolism, and Reagents Related TheretoAbandonedMay 13, 15Jan 07, 16[A61K]
2014/0213,518 METHODS OF ENHANCING FUNCTIONING OF THE LARGE INTESTINEAbandonedNov 05, 13Jul 31, 14[C07K]
8603976 Methods of enhancing functioning of the large intestineExpiredAug 30, 12Dec 10, 13[A61K, A61P]
8278273 Methods of enhancing functioning of the large intestineExpiredMay 06, 11Oct 02, 12[A61K, G01N]
2011/0223,108 GLUCAGON-LIKE PEPTIDE-2 AND ITS THERAPEUTIC USEAbandonedDec 22, 10Sep 15, 11[A61K, A61P, C07K]
7862824 Enhancement of GLP-2 activity of suppressing appetiteExpiredApr 22, 04Jan 04, 11[A61K]
2004/0132,025 Ampk-related serine/threonine kinase, designated snarkAbandonedJul 02, 03Jul 08, 04[C07H, C12Q, C12N]
2003/0109,449 Antagonists of intestinotrophic GLP-2 peptidesAbandonedNov 18, 02Jun 12, 03[A61K, G01N, C07K]
6489295 Antagonists of intestinotrophic GLP-2 peptidesExpiredJan 19, 99Dec 03, 02[A61K, C07K]
2002/0123,461 Enhancement of GLP-2 activityAbandonedFeb 01, 02Sep 05, 02[A61K]
2002/0045,173 GLP-2 receptor gene promoter and uses thereofAbandonedApr 13, 01Apr 18, 02[C07H, C12Q, C12P, C12N, A01K, C07K]
5994500 Antagonists of intestinotrophic GLP-2 peptidesExpiredJul 19, 96Nov 30, 99[C07K]
5846937 Method of using exendin and GLP-1 to affect the central nervous systemExpiredMar 03, 97Dec 08, 98[A61K, C07K]

Top Inventors for This Owner

Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More

We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!

We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.